novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

New options to manage high risk patients with dyslipidemia

20 Setembro 2016

Luis Masana
Hospital Universitario “Sant Joan”
Universitat Rovira i Virgili
REUS – Spain

Left atrial appendage closure. What's the evidence?

20 Setembro 2016
0

ACS: implementation of new treatments lead to better outcomes in the real world

20 Setembro 2016
0

-->